Upgrades:
Kimco Realty (NYSE:KIM) was upgraded by analysts at Argus
from a "hold" rating to a "buy" rating in a research report
issued on Wednesday, Analyst Ratings Network reports. The brokerage currently
has a $27.00 target price on the real estate investment trust's stock. Argus'
price objective indicates a potential upside of 7.02% from the stock's previous
close.
KIM has been the topic of a number of other research
reports. Evercore ISI upgraded Kimco Realty from an "in-line" rating
to an "outperform" rating and lifted their target price for the
company from $24.00 to $26.00 in a research report on Monday, November 22nd.
Wolfe Research initiated coverage on Kimco Realty in a research report on
Thursday, September 23rd. They issued a "market perform" rating and a
$24.00 target price on the stock. Citigroup lifted their target price on Kimco
Realty from $26.00 to $28.00 and gave the company a "buy" rating in a
research report on Thursday, December 2nd. Truist lifted their target price on
Kimco Realty from $25.00 to $27.00 and gave the company a "buy"
rating in a research report on Friday, December 10th. Finally, Deutsche Bank
Aktiengesellschaft downgraded Kimco Realty from a "buy" rating to a
"hold" rating and boosted their price objective for the company from
$24.00 to $26.00 in a report on Monday. Four analysts have rated the stock with
a hold rating and twelve have assigned a buy rating to the stock. According to
MarketBeat.com, the company currently has a consensus rating of "Buy"
and a consensus price target of $25.60. Read
more …

MetLife (NYSE:MET) was upgraded by Evercore ISI from an
"in-line" rating to an "outperform" rating in a report
issued on Wednesday, Price Targets.com reports. The brokerage presently has a
$75.00 price objective on the financial services provider's stock, up from
their previous price objective of $67.00. Evercore ISI's price objective
suggests a potential upside of 15.49% from the company's current price.
Several other research analysts also recently weighed in on
MET. The Goldman Sachs Group assumed coverage on shares of MetLife in a
research report on Thursday, December 2nd. They issued a "buy" rating
and a $77.00 target price on the stock. Wells Fargo & Company dropped their
target price on shares of MetLife from $75.00 to $74.00 and set an
"overweight" rating on the stock in a research report on Tuesday.
Barclays boosted their price objective on shares of MetLife from $69.00 to
$72.00 and gave the company an "overweight" rating in a research
report on Tuesday, October 12th. Finally, Morgan Stanley boosted their price
objective on shares of MetLife from $74.00 to $75.00 and gave the company an
"overweight" rating in a research report on Thursday, October 14th.
Thirteen research analysts have rated the stock with a buy rating, Based on
data from MarketBeat, MetLife has an average rating of "Buy" and an
average price target of $69.29. Read
more …

Pfizer (NYSE:PFE) was upgraded by Bank of America from a
"neutral" rating to a "buy" rating in a report released on
Wednesday, The Fly reports.
Several other research firms have also weighed in on PFE.
Sanford C. Bernstein raised their price objective on shares of Pfizer from
$44.00 to $65.00 and gave the company a "market perform" rating in a
research report on Monday. UBS Group upgraded shares of Pfizer from a
"neutral" rating to a "buy" rating and raised their target
price for the stock from $52.00 to $60.00 in a report on Monday, December 13th.
Truist raised their target price on shares of Pfizer from $43.00 to $58.00 and
gave the stock a "buy" rating in a report on Wednesday, November
24th. JPMorgan Chase & Co. set a $53.00 target price on shares of Pfizer in
a report on Monday, December 13th. Finally, Barclays set a $54.00 target price
on shares of Pfizer in a report on Tuesday. Nine analysts have rated the stock
with a hold rating, twelve have assigned a buy rating and one has issued a
strong buy rating to the stock. Based on data from MarketBeat, the company
currently has a consensus rating of "Buy" and a consensus price
target of $56.15. Read
more …

Suncor Energy (NYSE:SU) (TSE:SU) was upgraded by equities
research analysts at Wells Fargo & Company from an "equal weight"
rating to an "overweight" rating in a report released on Wednesday,
The Fly reports.
A number of other analysts have also recently commented on
SU. Credit Suisse Group upped their price objective on shares of Suncor Energy
from C$36.00 to C$42.00 and gave the company an "outperform" rating
in a research report on Tuesday, November 2nd. BMO Capital Markets upped their
price objective on shares of Suncor Energy from C$39.00 to C$43.00 and gave the
company an "outperform" rating in a research report on Friday,
October 29th. TD Securities increased their target price on Suncor Energy from
C$39.00 to C$40.00 and gave the stock a "buy" rating in a report on
Thursday, October 28th. Scotiabank increased their target price on Suncor
Energy from C$33.00 to C$37.00 and gave the stock an "outperform"
rating in a report on Friday, November 19th. Finally, JPMorgan Chase & Co.
upgraded Suncor Energy from a "neutral" rating to an
"overweight" rating and increased their target price for the stock
from $29.00 to $39.00 in a report on Thursday, October 28th. Two investment
analysts have rated the stock with a hold rating and thirteen have given a buy
rating to the company. According to data from MarketBeat.com, the stock
presently has a consensus rating of "Buy" and a consensus target
price of $37.86. Read
more …